ZA997821B - Methods to potentiate intravenous estramustine phosphate. - Google Patents

Methods to potentiate intravenous estramustine phosphate.

Info

Publication number
ZA997821B
ZA997821B ZA9907821A ZA997821A ZA997821B ZA 997821 B ZA997821 B ZA 997821B ZA 9907821 A ZA9907821 A ZA 9907821A ZA 997821 A ZA997821 A ZA 997821A ZA 997821 B ZA997821 B ZA 997821B
Authority
ZA
South Africa
Prior art keywords
potentiate
methods
estramustine phosphate
intravenous estramustine
intravenous
Prior art date
Application number
ZA9907821A
Inventor
Michael S Kopreski
Beryl Asp
Bo Fredholm
Per-Olv Gunnarsson
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of ZA997821B publication Critical patent/ZA997821B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
ZA9907821A 1998-03-27 1999-12-22 Methods to potentiate intravenous estramustine phosphate. ZA997821B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7954298P 1998-03-27 1998-03-27

Publications (1)

Publication Number Publication Date
ZA997821B true ZA997821B (en) 2000-08-01

Family

ID=22151209

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9907821A ZA997821B (en) 1998-03-27 1999-12-22 Methods to potentiate intravenous estramustine phosphate.

Country Status (16)

Country Link
EP (1) EP1003521A4 (en)
JP (1) JP2001508810A (en)
KR (1) KR20010021656A (en)
CN (2) CN1636598A (en)
AU (1) AU750010B2 (en)
BR (1) BR9906425A (en)
CA (1) CA2295049A1 (en)
EA (1) EA004647B1 (en)
HU (1) HUP0200547A3 (en)
ID (1) ID24504A (en)
IL (1) IL133612A0 (en)
NO (1) NO20002343D0 (en)
NZ (1) NZ501987A (en)
PL (1) PL342969A1 (en)
WO (1) WO1999049869A1 (en)
ZA (1) ZA997821B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003201D0 (en) * 2000-02-11 2000-04-05 Pharmacia & Upjohn Spa Method to potentiate the therapeutic efficacy of taxane and derivatives thereof
US6436913B1 (en) * 2000-07-25 2002-08-20 Pharmacia & Upjohn Company Use of estramustine phosphate in the treatment of bone metastasis
RU2471511C1 (en) * 2011-05-04 2013-01-10 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения и социального развития Российской Федерации (ФГБУ "РНИОИ" Минздравсоцразвития России) Method of treating colonic liver metastases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS617292A (en) * 1984-06-20 1986-01-13 Japan Atom Energy Res Inst Method for producing estracyt compound bonded with carcinostatic agent
US5077056A (en) * 1984-08-08 1991-12-31 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
MX9203808A (en) * 1987-03-05 1992-07-01 Liposome Co Inc HIGH DRUG CONTENT FORMULATIONS: LIPID, FROM LIPOSOMIC-ANTINEOPLASTIC AGENTS.
AU3922193A (en) * 1992-03-23 1993-10-21 Georgetown University Liposome encapsulated taxol and a method of using the same
FR2697752B1 (en) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Antitumor compositions containing taxane derivatives.

Also Published As

Publication number Publication date
KR20010021656A (en) 2001-03-15
NZ501987A (en) 2002-10-25
CN1273530A (en) 2000-11-15
NO20002343L (en) 2000-05-04
EP1003521A1 (en) 2000-05-31
JP2001508810A (en) 2001-07-03
WO1999049869A1 (en) 1999-10-07
AU3353399A (en) 1999-10-18
EA199901081A1 (en) 2000-12-25
BR9906425A (en) 2000-07-11
CA2295049A1 (en) 1999-10-07
CN1636598A (en) 2005-07-13
NO20002343D0 (en) 2000-05-04
EA004647B1 (en) 2004-06-24
HUP0200547A3 (en) 2003-07-28
PL342969A1 (en) 2001-07-16
ID24504A (en) 2000-07-20
AU750010B2 (en) 2002-07-11
EP1003521A4 (en) 2003-07-23
IL133612A0 (en) 2001-04-30
HUP0200547A2 (en) 2002-07-29

Similar Documents

Publication Publication Date Title
PT1064047E (en) Electro-nerve stimulator systems
SG97865A1 (en) Accelerator system
AU5130299A (en) Wrist-mounted i.v. administration set
EP1135856A4 (en) Single ended interconnect systems
ZA200005368B (en) Hydraulic fastening of components.
AU6324999A (en) Combined mouse
GB2340603B (en) Fluid-gauging systems
ZA997821B (en) Methods to potentiate intravenous estramustine phosphate.
GB2345317B (en) Fuel-injection system
ZA993063B (en) 2"-deoxy hygromycin derivatives.
GB9802975D0 (en) Structural systems
EP1109566A4 (en) Gcp
GB9820623D0 (en) Connectors
TW511476U (en) Linking component
EP1073669A4 (en) Gcp
AU2998399A (en) Anticancer agents
GB9803154D0 (en) Tolerance
GB9809468D0 (en) Shelving
GB9807830D0 (en) Shelving
GB9803662D0 (en) The connector can
GB9825895D0 (en) Improved shelving system
ZA994635B (en) Fasteners.
GB9826469D0 (en) Snapfast bolt
GB9904078D0 (en) Technical accelerator
GB9825454D0 (en) Easy dig